Internal Medicine, Gastroenterology · Oakland, CA
NPI
1487733531
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
275 W Macarthur Blvd
Oakland, CA, 94611
Phone (510) 752-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,312
25 services
Medicare patients, 2024
20
Average age 72
Drug cost, 2024
$492K
823 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly A Cusato prescribed most often to Medicare patients was Omeprazole, with 114 prescriptions and refills. In total Kimberly A Cusato wrote 823 Medicare prescriptions that cost $492K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Omeprazole Generic | 114 | 355 | 47 | $1,356 |
| Mesalamine Generic | 83 | 234 | 29 | $60K |
| Famotidine Generic | 53 | 177 | 25 | $889 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 44 | 44 | 44 | $1,000 |
| Pantoprazole Sodium Generic | 39 | 118 | 17 | $536 |
| Azathioprine Generic | 37 | 119 | 13 | $1,421 |
| Adefovir Dipivoxil Generic | 30 | 30 | Under 11 | $18K |
| Baclofen Generic | 29 | 36 | Under 11 | $293 |
| Entecavir Generic | 28 | 85 | Under 11 | $1,235 |
| Zenpep Lipase/Protease/Amylase | 26 | 70 | 11 | $128K |
| Ursodiol Generic | 24 | 76 | Under 11 | $5,929 |
| Nitro-Bid Nitroglycerin | 20 | 20 | Under 11 | $287 |
| Balsalazide Disodium Generic | 18 | 38 | Under 11 | $4,299 |
| Ondansetron Odt Ondansetron | 18 | 18 | Under 11 | $159 |
| Budesonide Dr Budesonide | 17 | 30 | Under 11 | $1,397 |
Brand drugs: 126 claims; generic drugs: 684 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kimberly A Cusato were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.